Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism.
Approximately 60% of breast cancer patients have hormone-dependent breast cancer containing estrogen receptors and requiring estrogen for tumor growth. The extent of estrogen biosynthesis and metabolism in the breast cancer tissue microenvironment influences breast-tumor development and growth, and endogenous and exogenous agents may alter the levels of hormonally active estrogens and their metabolites. Isoflavonoid phytoestrogens such as genistein exhibit numerous biochemical activities; however, their effects on estrogen biosynthesis and metabolism in breast cancer cells have not been fully examined. MCF-7 cells (hormone-dependent) and MBA-MB-231 cells (hormone-independent) were treated with genistein (100 nM) for five days and then incubated with radiolabeled estradiol (100 nM, 2.5 microCi) for 0 to 48 h. Media were extracted with ethyl acetate, and the organic residues analyzed by reverse-phase HPLC with a radioactivity flow detector. The major metabolite formed in all cases is estrone, although differences were observed between the cell lines and the various drug treatments. The formation of estrone in untreated MCF-7 cells (approximately 9.3% of radioactivity at 24 h) is relatively limited, in contrast to untreated MDA-MB-231 cells (approximately 32.0% of radioactivity at 24 h). Treatment of MCF-7 cells with 100 nM genistein increased the conversion of estradiol to estrone up to 19.5% in 24 h. The effect of genistein on estrone formation in MDA-MB-231 cells resulted in 37.7% of the radioactivity being estrone. Thus, genistein treatment of breast cancer cells resulted in increased 17-betahydroxysteroid dehydrogenase activity and elevated formation of estrone. Increased levels of oxidative 17-betahydroxysteroid dehydrogenase activity (Type II) were confirmed by Western blots. Therefore, exposure of breast cancer cells to genistein results in elevated conversion of estradiol to estrogenically weaker or inactive metabolites. The regulation of breast-tissue aromatase by exogenous agents such as drugs and environmental agents is being investigated. The benzopyranone-ring system is a molecular scaffold of considerable interest, and this scaffold is found in flavonoid natural products that have weak aromatase inhibitory activity. Medicinal chemistry efforts focus on diversifying the benzopyranone scaffold and utilizing combinatorial chemistry approaches to construct small benzopyranone libraries as potential aro- matase inhibitors. Several compounds in the initial libraries have demonstrated moderate aromatase inhibitory activity in screening assays.
Brueggemeier
R W
RW
College of Pharmacy and OSU Comprehensive Cancer Center, The Ohio State University, Columbus 43210, USA. Brueggemeier.1@osu.edu
Gu
X
X
Mobley
J A
JA
Joomprabutra
S
S
Bhat
A S
AS
Whetstone
J L
JL
D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D001141:Aromatase / Q000096:biosynthesis* / Q000378:metabolism; D001578:Benzopyrans / Q000378:metabolism; D015153:Blotting, Western; D001943:Breast Neoplasms / Q000378:metabolism / Q000517:prevention & control; D002470:Cell Survival / Q000187:drug effects; D020650:Combinatorial Chemistry Techniques; D004958:Estradiol / Q000378:metabolism; D004967:Estrogens / Q000096:biosynthesis* / Q000378:metabolism; D004968:Estrogens, Non-Steroidal / Q000737:chemistry / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007202:Indicators and Reagents; D007529:Isoflavones; D009376:Neoplasms, Hormone-Dependent / Q000378:metabolism / Q000517:prevention & control; D019151:Peptide Library; D048789:Phytoestrogens; D028321:Plant Preparations; D014407:Tumor Cells, Cultured
D000972:Antineoplastic Agents, Phytogenic; D001578:Benzopyrans; D004967:Estrogens; D004968:Estrogens, Non-Steroidal; D007202:Indicators and Reagents; D007529:Isoflavones; D019151:Peptide Library; D048789:Phytoestrogens; D028321:Plant Preparations; D004958:Estradiol; D001141:Aromatase